Abstract Whitehouse, Peter J. and Kin Sing Au: Cholinergic receptors in aging and
Alzheimer's disease. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 1986, 10 (3–5): 665 …

Alzheimer's disease (AD) and Parkinson's disease (PD) and to a lesser extent progressive
supranuclear palsy are characterized by dysfunction of the cholinergic basal forebrain …

The main objective of the present study was to determine whether cholinergic markers
(choline acetyltransferase activity and nicotinic and muscarinic receptors) are altered in …

Experimental lesions using the retrogradely transported toxin, volkensin, have been used in
conjunction with autoradiography to investigate the cellular localization of 5–HT1A …

The past decade has witnessed an enormous increase in our knowledge of the variety and
complexity of neuropathological and neurochemical changes in Alzheimer's disease …

Multiple neuroreceptor changes are present in Alzheimer disease. These observations are
based upon analysis from autopsy brain tissue or more seldom from neurosurgical biopsies …

The status of various cholinergic markers was compared in Alzheimer's and Parkinson's
diseases. Rather unexpectedly, similar decrements were observed in choline …

• Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy are all
characterized by loss of neurons in the basal forebrain cholinergic system and by associated …

Optimum immunohistochemical methods were established to immuno-localize nicotinic
acetylcholine receptor α4 and β2 subunits in temporal cortex and substantia nigra of normal …